Prasugrel hæmmer ikke CYP2C9, eftersom det ikke påvirker S- warfarins farmakokinetik.
Medicinal products metabolised by CYP2C9: prasugrel did not inhibit CYP2C9, as it did not affect the pharmacokinetics of S-warfarin.